Name | Title | Contact Details |
---|
MedAmerica is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Synedgen is a Claremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Caregiver, Inc. is one of the largest providers of support services to people with intellectual and developmental disabilities and traumatic brain injury in the United States. We currently operate in Texas and Tennessee under multiple local brands, including: Daybreak Community Services Unified Care Group Southern Concepts River Gardens St. Giles Omni Support Services/Caregiver of Tennessee Our Mission is "Enabling people with intellectual and developmental disabilities to lead their unique lives with dignity, independence and inclusion." We believe in recruiting, training and developing the best people to support the individuals we serve; enabling them with tools and technology to provide individualized supports. We care deeply about the people we serve and strive to serve their unique goals and dreams. We work with integrity, accountability, transparency, and compassion in everything we do, because we understand those we serve have a choice in providers. We offer residential, intermediate care facility, supported living/foster care, day support, community integration and employment support services in both Texas and Tennessee. In addition, Caregiver has a newly developed Behavioral Support Services team supporting those we serve in Texas.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
Insilicomed, Inc. is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.